MCT1 gene silencing enhances the immune effect of dendritic cells on cervical cancer cells

被引:1
|
作者
Sui, Xiaoxin [1 ]
Xi, Xiaowei [2 ]
机构
[1] Naval Med Univ, Shanghai Changzheng Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Obstet & Gynecol, Shanghai 201620, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
dendritic cells; cervical cancer; immunity; MCT1; LACTIC-ACID; T-CELLS; TUMOR;
D O I
10.17219/acem/171446
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Dendritic cells (DCs) are a key class of immune cells that migrate to the draining lymph nodes and present processed antigenic peptides to lymphocytes after being activated by external stimuli, thereby establishing adaptive immunity. Moreover, DCs play an important role in tumor immunity.Objectives. The aim of the study was to investigate whether MCT1 gene silencing in DCs affects their ability to mount an immune response against cervical cancer cells.Materials and methods. We silenced the expression of MCT1 in DCs from mouse bone marrow (BM) by infection with adenovirus. The surface antigen profile of DCs was analyzed by flow cytometry and cytokine secretion was evaluated using enzyme-linked immunosorbent assay (ELISA) following sodium lactate (sLA) exposure and lipopolysaccharide (LPS) stimulation. Then, various groups of DC-induced cytotoxic T lymphocytes (CTLs) were prepared and their cytotoxicity against U14 was tested.Results. Without sLA exposure, silencing MCT1 did not affect the expression of CD1a, CD80, CD83, CD86, and major histocompatibility complex class II (MHCII) in DCs after LPS challenge. Similar results were found for interleukin (IL)-6, IL-12 p70 and tumor necrosis factor alpha (TNF-alpha). After sLA exposure, silencing MCT1 significantly decreased the expression of CD1a, CD80, CD83, CD86, and MHCII in DCs after the LPS challenge, as well as the secretion of IL-6, IL-12 p70 and TNF-alpha. In addition, sLA exposure significantly reduced the toxicity and inhibited the proliferation of DC-induced CTLs compared to U14 cells in vitro and in vivo. However, silencing MCT1 significantly attenuated the changes caused by sLA exposure. At the same time, in the absence of sLA, silencing MCT1 did not affect the toxicity nor inhibit the proliferation of DC-induced CTLs on U14 cells. Conclusions. Lactate exposure reduces the immune effect of DCs on cervical cancer cells, but MCT1 gene silencing attenuates these alterations.
引用
收藏
页码:739 / 749
页数:11
相关论文
共 50 条
  • [21] Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells
    Yi Zhang
    Fu-qiang Chen
    Ye-hong Sun
    Shu-yan Zhou
    Ti-yuan Li
    Rui Chen
    Journal of Experimental & Clinical Cancer Research, 30
  • [22] Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells
    Zhang, Yi
    Chen, Fu-qiang
    Sun, Ye-hong
    Zhou, Shu-yan
    Li, Ti-yuan
    Chen, Rui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [23] Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD plus Depletion in Cancer Cells
    Benjamin, Don
    Robay, Dimitri
    Hindupur, Sravanth K.
    Pohlmann, Jens
    Colombi, Marco
    El-Shemerly, Mahmoud Y.
    Maira, Sauveur-Michel
    Moroni, Christoph
    Lane, Heidi A.
    Hall, Michael N.
    CELL REPORTS, 2018, 25 (11): : 3047 - +
  • [24] Functional evidence for a monocarboxylate transporter (MCT) in strial marginal cells and molecular evidence for MCT1 and MCT2 in stria vascularis
    Shimozono, M
    Scofield, MA
    Wangemann, P
    HEARING RESEARCH, 1997, 114 (1-2) : 213 - 222
  • [25] Silencing the livin gene enhances the cytotoxic effects of anticancer drugs on colon cancer cells
    Oh, Bo Young
    Kim, Kwang Ho
    Chung, Soon Sup
    Lee, Ryung-Ah
    Annals of Surgical Treatment and Research, 2016, 91 (06) : 273 - 277
  • [26] Regulation of Mct1 by cAMP-dependent internalization in rat brain endothelial cells
    Smith, Jeffrey P.
    Uhernik, Amy L.
    Li, Lun
    Liu, Zejian
    Drewes, Lester R.
    BRAIN RESEARCH, 2012, 1480 : 1 - 11
  • [27] PKC activation stimulates MCT1 promoter activity in Caco2 cells
    Saksena, S
    Gill, RK
    Tyagi, S
    Alrefai, WA
    Borthakur, A
    Ramaswamy, K
    Dudeja, PK
    GASTROENTEROLOGY, 2004, 126 (04) : A295 - A295
  • [28] Immunological role of dendritic cells in cervical cancer
    Manickam, Alagar
    Sivanandham, Muthukumaran
    Tourkova, Irina L.
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 155 - 162
  • [29] Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells
    Lopes-Coelho, Filipa
    Nunes, Carolina
    Gouveia-Fernandes, Sofia
    Rosas, Rita
    Silva, Fernanda
    Gameiro, Paula
    Carvalho, Tania
    da Silva, Maria Gomes
    Cabecadas, Jose
    Dias, Sergio
    Goncalves, Luis G.
    Serpa, Jacinta
    ONCOTARGET, 2017, 8 (47) : 82803 - 82823
  • [30] Enhanced cerebral expression of MCT1 and MCT2 in a rat ischemia model occurs in activated microglial cells
    Moreira, Tiago J. T. P.
    Pierre, Karin
    Maekawa, Fumihiko
    Repond, Cendrine
    Cebere, Aleta
    Liljequist, Sture
    Pellerin, Luc
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 (07): : 1273 - 1283